Omnitrope (Somatropin) is a human growth hormone (HGH). It is used for treatment of adults patients who have severe growth hormone deficiency associated with multiple hormone deficiencies as a result of known hypothalamic or pituitary pathology and who have at least one known deficiency of a pituitary hormone not being prolactin.

Omnitrope is used for growth disturbance associated with Turner syndrome and chronic renal insufficiency. It is also use for treatment of children with growth failure due to growth hormone deficiency (GHD), Prader-Willi Syndrome, Small for Gestational Age, Turner Syndrome and Idiopathic Short Stature.

Human growth hormone (HGH) is responsible for bone growth as well as protein and carbohydrate metabolism in the body. It is separated from the anterior pituitary (adenohypophysis). The freed Growth Hormone itself has no direct effect and stimulates the liver to produce and release insulin-like growth factor IGF-1. Thus, its effect is expressed in increased metabolism and particularly protein synthesis.

Growth Hormone (GH) can be used for athletic performance enhancement and anti-aging treatment. The major off label uses of GH are for anti aging and for bodybuilding. Growth Hormone is one of the most widely abused drugs by sports athletes because the drug is somewhat difficult to detect. The majority of bodybuilder use a whole cocktail of drugs together with HGH.

In patients above 60-65 years, they may be more sensitive to the action of Omnitrope and therefore may be more prone to develop adverse reactions. A lower starting dose and smaller dose increments should be considered for older patients.